Clinical Trial Update: An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intra-lesional 3% polidocanol for digital myxoid cysts (ganglion cysts) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ganglion Cyst

Drugs mentioned

• polidocanol (polidocanol)

Snippet

Sponsor: University of Edinburgh | Conditions: Ganglion Cysts | Phase 4 | Status: TERMINATED